Dynamics of Dystrophin's Actin-Binding Domain.

Biophys J

Department of Biochemistry, Molecular Biology & Biophysics, University of Minnesota, Minneapolis, Minnesota. Electronic address:

Published: August 2018

We have used pulsed electron paramagnetic resonance, calorimetry, and molecular dynamics simulations to examine the structural mechanism of binding for dystrophin's N-terminal actin-binding domain (ABD1) and compare it to utrophin's ABD1. Like other members of the spectrin superfamily, dystrophin's ABD1 consists of two calponin-homology (CH) domains, CH1 and CH2. Several mutations within dystrophin's ABD1 are associated with the development of severe degenerative muscle disorders Duchenne and Becker muscular dystrophies, highlighting the importance of understanding its structural biology. To investigate structural changes within dystrophin ABD1 upon binding to actin, we labeled the protein with spin probes and measured changes in inter-CH domain distance using double-electron electron resonance. Previous studies on the homologous protein utrophin showed that actin binding induces a complete structural opening of the CH domains, resulting in a highly ordered ABD1-actin complex. In this study, double-electron electron resonance shows that dystrophin ABD1 also undergoes a conformational opening upon binding F-actin, but this change is less complete and significantly more structurally disordered than observed for utrophin. Using molecular dynamics simulations, we identified a hinge in the linker region between the two CH domains that grants conformational flexibility to ABD1. The conformational dynamics of both dystrophin's and utrophin's ABD1 showed that compact conformations driven by hydrophobic interactions are preferred and that extended conformations are energetically accessible through a flat free-energy surface. Considering that the binding free energy of ABD1 to actin is on the order of 6-7 kcal/mole, our data are compatible with a mechanism in which binding to actin is largely dictated by specific interactions with CH1, but fine tuning of the binding affinity is achieved by the overlap between conformational ensembles of ABD1 free and bound to actin.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6084637PMC
http://dx.doi.org/10.1016/j.bpj.2018.05.039DOI Listing

Publication Analysis

Top Keywords

abd1
10
dynamics dystrophin's
8
actin-binding domain
8
molecular dynamics
8
dynamics simulations
8
mechanism binding
8
utrophin's abd1
8
dystrophin's abd1
8
dystrophin abd1
8
binding actin
8

Similar Publications

Identification of Novel Nexilin Splice Variants in Mouse and Human Tissues.

Cells

December 2024

Institute of Biochemistry II, Jena University Hospital, Friedrich Schiller University Jena, Nonnenplan 2-4, 07743 Jena, Germany.

There is no doubt that the proper development of the heart is important for its correct function, in addition, maturation processes of the heart are crucial as well. The actin-binding protein nexilin seems to take over central roles in the latter processes, as nexilin-deficient mice are phenotypically inconspicuous at birth but die within short time thereafter. Recently, it has been proposed that nexilin plays a role in the formation and function of transverse tubules (T-tubules), which are essential for excitation-contraction coupling in the hearts of mature animals.

View Article and Find Full Text PDF

Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1.

Mol Ther Nucleic Acids

December 2023

Department of Regenerative Science and Medicine, Shinshu University, Matsumoto 390-8621, Japan.

Article Synopsis
  • Exon-skipping therapy is a potential treatment for Duchenne muscular dystrophy (DMD) by targeting specific exons in the dystrophin gene, particularly focusing on a mild variant known as Δ3-9.
  • A study compared human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) with either the Δ3-9 deletion, a frameshifting deletion (Δ3-7), or intact dystrophin, revealing that the Δ3-9 variant mimicked the expression patterns and electrical properties of healthy heart cells.
  • Antisense oligonucleotides targeting exon 8 successfully restored functional dystrophin and improved cell characteristics in the Δ3-7 cells, suggesting that modifying
View Article and Find Full Text PDF

Diverse extracellular proteins negatively regulate WNT signaling. One such regulator is adenomatosis polyposis coli down-regulated 1 (APCDD1), a conserved single-span transmembrane protein. In response to WNT signaling in a variety of tissues, transcripts are highly up-regulated.

View Article and Find Full Text PDF

Duchenne muscular dystrophy is a lethal muscle disease, caused by mutations in the gene encoding dystrophin, an actin-binding cytoskeletal protein. Absence of functional dystrophin results in muscle weakness and degeneration, eventually leading to cardiac and respiratory failure. Strategies to replace the missing dystrophin via gene therapy have been intensively pursued.

View Article and Find Full Text PDF

Plastins/fimbrins are conserved actin-bundling proteins contributing to motility, cytokinesis and other cellular processes by organizing strikingly different actin assemblies as in aligned bundles and branched networks. We propose that this ability of human plastins stems from an allosteric communication between their actin-binding domains (ABD1/2) engaged in a tight spatial association. Here we show that ABD2 can bind actin three orders of magnitude stronger than ABD1, unless the domains are involved in an equally strong inhibitory engagement.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!